NIMH perspectives on future directions in neuroimaging for mental health
- PMID: 38898207
- PMCID: PMC11525989
- DOI: 10.1038/s41386-024-01900-8
NIMH perspectives on future directions in neuroimaging for mental health
Erratum in
-
Correction: Neuropsychopharmacology Volume 50 Issue 1.Neuropsychopharmacology. 2025 May;50(6):1019-1020. doi: 10.1038/s41386-025-02087-2. Neuropsychopharmacology. 2025. PMID: 40108440 Free PMC article. No abstract available.
Abstract
NIMH's mission is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. New imaging techniques hold great promise for improving our understanding of the pathophysiology of mental illnesses, stratifying patients for treatment selection, and developing a personalized medicine approach. Here, we highlight emerging and promising new technologies that are likely to be vital in helping NIMH accomplish its mission, the potential for utilizing multimodal approaches to study mental illness, and considerations for data analytics and data sharing.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
Dr. Lisanby is inventor on patents and patent applications on electrical and magnetic brain stimulation therapy systems held by the NIH and Columbia University, with no remuneration. The opinions expressed in this article are the author’s own and do not reflect the views of the National Institutes of Health, the Department of Health and Human Services, or the United States government. The remaining authors have nothing to disclose.
References
-
- Carson RE, Naganawa M, Toyonaga T, Koohsari S, Yang Y, Chen MK, et al. Imaging of synaptic density in neurodegenerative disorders. J Nucl Med. 2022;63:60S–7S. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
